Genetic Technologies Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Kevin Camilleri
Chief executive officer
AU$296.1k
Total compensation
| CEO salary percentage | 87.0% |
| CEO tenure | 3.3yrs |
| CEO ownership | n/a |
| Management average tenure | 3.3yrs |
| Board average tenure | 5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | AU$296k | AU$258k | -AU$12m |
| Mar 31 2024 | n/a | n/a | -AU$12m |
| Dec 31 2023 | n/a | n/a | -AU$13m |
| Sep 30 2023 | n/a | n/a | -AU$12m |
| Jun 30 2023 | AU$281k | AU$233k | -AU$12m |
| Mar 31 2023 | n/a | n/a | -AU$10m |
| Dec 31 2022 | n/a | n/a | -AU$9m |
| Sep 30 2022 | n/a | n/a | -AU$8m |
| Jun 30 2022 | AU$285k | AU$212k | -AU$7m |
Compensation vs Market: Kevin's total compensation ($USD185.20K) is below average for companies of similar size in the German market ($USD469.36K).
Compensation vs Earnings: Kevin's compensation has increased whilst the company is unprofitable.
CEO
Kevin Camilleri (47 yo)
3.3yrs
Tenure
AU$296,120
Compensation
Mr. Kevin Camilleri serves as Chief Executive Officer of EasyDNA at Genetic Technologies Limited since August 16, 2021. Mr. Camilleri joined the Genetic Technologies Limited in 2021. He has been Chief Oper...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer of EasyDNA | 3.3yrs | AU$296.12k | no data | |
| CFO & Company Secretary | less than a year | no data | no data | |
| Consultant | 5.4yrs | AU$180.45k | no data | |
| Director of Clinical & Scientific Affairs | no data | no data | no data |
3.3yrs
Average Tenure
Experienced Management: DU80's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Non-Executive Director | 10.3yrs | AU$74.88k | 0.065% € 2.2k | |
| Independent Non-Executive Chairman | 6.9yrs | AU$150.19k | 2.54% € 86.5k | |
| Non-Independent Non-Executive Director | 6.9yrs | AU$87.44k | 1.55% € 52.6k | |
| Member of Scientific & Medical Advisory Board | 3.1yrs | no data | no data | |
| Member of Scientific & Medical Advisory Board | 3.1yrs | no data | no data | |
| Member of Scientific & Medical Advisory Board | 3.1yrs | no data | no data |
5.0yrs
Average Tenure
66yo
Average Age
Experienced Board: DU80's board of directors are considered experienced (5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 09:38 |
| End of Day Share Price | 2024/10/16 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Genetic Technologies Limited is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Marc Kennis | APP Securities Pty Ltd. |
| Kevin DeGeeter | Ladenburg Thalmann & Company |
| Chris Kallos | MST Financial Services Pty Limited |